IL17A and psoriasis: They described that improved recovery of the skin was associated with increased IL-17A and TGF-β in the skin of mice treated with BM- or AD-MSCs, and they hypothesized that TGF-β promoted the controlled differentiation of keratinocytes, resulting in the decreased severity of psoriasis [142].